5.36
-0.24
(-4.29%)
At close: April 15 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
406,533
428,567
433,582
501,527
Total Liabilities Net Minority Interest
76,495
78,609
75,650
60,575
Total Equity Gross Minority Interest
330,038
349,958
357,932
440,952
Total Capitalization
330,038
349,958
357,932
440,952
Common Stock Equity
330,038
349,958
357,932
440,952
Capital Lease Obligations
37,371
41,464
44,104
21,892
Net Tangible Assets
326,007
343,924
350,416
420,786
Working Capital
321,587
343,113
350,175
411,978
Invested Capital
330,038
349,958
357,932
440,952
Tangible Book Value
326,007
343,924
350,416
420,786
Total Debt
37,371
41,464
44,104
21,892
Share Issued
49,572.75
38,014
37,279.99
36,768.04
Ordinary Shares Number
49,572.75
38,014
37,279.99
36,768.04
12/31/2021 - 12/7/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CVRX CVRx, Inc.
6.31
-3.37%
NPCE NeuroPace, Inc.
10.34
-3.09%
KIDS OrthoPediatrics Corp.
20.97
-0.05%
SERA Sera Prognostics, Inc.
3.3000
-1.20%
ICAD iCAD, Inc.
1.9300
+6.04%
CTKB Cytek Biosciences, Inc.
3.7200
-1.06%
ESTA Establishment Labs Holdings Inc.
31.47
+0.46%
SGHT Sight Sciences, Inc.
2.5200
+4.56%
LUNG Pulmonx Corporation
4.9200
-9.06%
PACB Pacific Biosciences of California, Inc.
1.2700
-3.79%